Vontobel Holding
ARKG icon

Vontobel Holding’s ARK Genomic Revolution ETF ARKG Stock Holding History

Vontobel Holding’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-197,320
Closed -$9.06M – 1021
2022
Q1 		$9.06M Sell
197,320
-3,636
-2% -$173K 0.08% 204
2021
Q4 		$12.3M Sell
200,956
-1,905
-0.9% -$132K 0.1% 167
2021
Q3 		$15.2M Sell
202,861
-10,212
-5% -$857K 0.13% 139
2021
Q2 		$19.7M Buy
213,073
+7,530
+4% +$640K 0.17% 112
2021
Q1 		$18.2M Buy
205,543
+3,513
+2% +$348K 0.14% 114
2020
Q4 		$18.8M Buy
+202,030
New +$16.1M 0.12% 120

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Vontobel Holding's ARKG Position: Q2 2022 in Review

Vontobel Holding sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 197,320 shares — an estimated $9.06M sold.

Vontobel Holding first reported a position in ARKG in Q4 2020 and held it in 6 quarters. The position peaked at $19.7M in Q2 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

  • Vontobel Holding reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
  • Vontobel Holding sold 197,320 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $9.06M.
  • Vontobel Holding first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 6 quarters.
  • Vontobel Holding's ARK Genomic Revolution ETF position peaked at $19.7M in Q2 2021.
  • 333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on Vontobel Holding's 13F filing for Q2 2022, filed 27 Jul 2022.